Notice of Results

RNS Number : 9666M
OptiBiotix Health PLC
13 May 2015
 

13 May 2015

Optibiotix Health Plc

 

Notice of Results

Analyst Briefing

 

OptiBiotix Health plc (AIM: OPTI), a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, will announce its results for the year ended 30 November 2014 on Friday 29 May 2015.

 

A briefing for analysts will take place at Walbrook PR, 4 Lombard Street, London EC3V 9HD at 9.30am on Friday 29 May 2015.

 

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email optibiotix@walbrookpr.com.

 

 

 For further information:

 

OptiBiotix Health plc

www.optibiotix.com

Stephen O'Hara, Chief Executive

Contact via Walbrook below



Cairn Financial Advisers LLP

Tel: 020 7148 7900

Liam Murray / Avi Robinson




Hybridan LLP (Joint Broker)

Claire Louise Noyce

 

Tel: 020 3713 4581



Peterhouse Corporate Finance Ltd (Joint Broker)

Tel: 020 7469 0936

Lucy Williams / Duncan Vasey




Walbrook PR Ltd

Tel: 020 7933 8780 or optibiotix@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

Mike Wort

Mob: 07900 608 002

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORLLFESEDIFLIE
UK 100

Latest directors dealings